Status:
COMPLETED
Study to Evaluate Safety, Efficacy and Tolerability of Clobetasol Propionate for Chronic Hand Dermatitis
Lead Sponsor:
Stiefel, a GSK Company
Collaborating Sponsors:
GlaxoSmithKline
Conditions:
Hand Dermatosis
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
The purpose of the study is to assess the safety, efficacy and tolerability of Clobetasol propionate foam in subjects with chronic dermatitis.
Detailed Description
The study is being conducted in order to obtain safety, efficacy and tolerability data for Clobetasol propionate foam in the treatment of chronic dermatitis. The subjects must have mild to moderate di...
Eligibility Criteria
Inclusion
- Subjects 18 years of age or older, with diagnosis of chronic dermatitis, able to complete the study and comply with study instructions.
- Female subjects of childbearing potential must have a negative pregnancy test. Sexually active women of childbearing potential participating in the study must have been using a medically acceptable form of contraception
Exclusion
- Use of systemic corticosteroid and/or other prohibited medications within 4 weeks of the baseline visit.
- Use of topical corticosteroid therapy and/or other prohibited topical medications within 2 weeks prior to the baseline visit
Key Trial Info
Start Date :
October 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 1 2009
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT00828464
Start Date
October 1 2008
End Date
January 1 2009
Last Update
October 3 2012
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Physicians Skin Care
Louisville, Kentucky, United States, 40217